Dendritic Cell (DC) therapy represents a new and promising immunotherapeutic approach for treatment of advanced cancer as well as for prevention of cancer. As Dr. Harmon Eyre, the VP of Research at the AMA commented: “Patients’ responses are far out of proportion to anything that any current therapy could do”. For decades, cancer researchers have been interested in immunologic treatments against cancer but with little progress. However, recent advances lead to successful implementation of Dendritic Cell therapy with reports of complete responses even in stage IV cancer patients who have failed all other therapies. Dendritic Cell (DC) Therapy or so-called Dendritic Cell vaccine is a newly emerging and potent form of immune therapy used to treat cancer. To learn more about vaccine and Dendritic Cell therapy for cancer, please read the following:

Using Dendritic Cells to Create Cancer Vaccines by Edgar Engleman for the Stanford School of Medicine Medcast lecture series